Table 2 Basal characteristics of participants across VAI quintiles, among women
Q1 | Q2 | Q3 | Q4 | Q5 | ||
|---|---|---|---|---|---|---|
N = 654 | N = 718 | N = 677 | N = 793 | N = 783 | P for trend | |
VAI range | 0.26-1.49 | 1.49-2.25 | 2.26-3.24 | 3.24-4.87 | 4.88-46.74 | |
Age (years) | 49.11 (14.46) | 48.5 (13.32) | 48.27 (12.78) | 48.46 (12.55) | 46.97 (11.87) | < 0.001 |
Life style modification | 250 (0.38) | 285 (0.40) | 256 (0.38) | 315 (0.40) | 303 (0.39) | 0.874 |
Smoking | 26 (0.04) | 21 (0.03) | 32 (0.05) | 26 (0.03) | 28 (0.04) | 0.846 |
Diabetes | 22 (0.03) | 47 (0.07) | 86 (0.13) | 150 (0.20) | 202 (0.27) | < 0.001 |
Anti-hypertensive drug | 53 (0.08) | 101 (0.14) | 121 (0.18) | 151 (0.19) | 197 (0.25) | < 0.001 |
Lipid lowering drug | 7 (0.01) | 11 (0.02) | 16 (0.02) | 44 (0.06) | 98 (0.13) | < 0.001 |
SBP (mm Hg) | 120.28 (20.67) | 121.48 (21.20) | 123.49 (19.52) | 123.22 (16.87) | 124.92 (18.51) | < 0.001 |
DBP (mm Hg) | 75.91 (11.83) | 77.66 (11.57) | 79.79 (11.60) | 80.03 (10.27) | 80.73 (11.31) | < 0.001 |
Weight (kg) | 67.94 (11.85) | 73.70 (11.28) | 76.37 (11.45) | 78.47 (11.72) | 80.30 (11.53) | < 0.001 |
Waist (cm) | 82.91 (10.83) | 88.91 (10.01) | 91.64 (9.58) | 93.85 (9.29) | 95.69 (8.85) | < 0.001 |
Height (cm) | 168.79 (7.05) | 169.09 (6.48) | 169.11 (6.48) | 168.74 (5.93) | 169.34 (6.70) | < 0.001 |
Hip circumference (cm) | 93.12 (6.73) | 96.22 (6.62) | 97.41 (6.06) | 98.36 (6.67) | 99.05 (6.50) | < 0.001 |
BMI (kg.m-2) | 23.84 (3.85) | 25.79 (3.79) | 26.67 (3.45) | 27.52 (3.54) | 27.97 (3.39) | < 0.001 |
WHpR | 88.81 (7.17) | 92.26 (6.50) | 93.96 (6.28) | 95.35 (6.01) | 96.59 (6.20) | < 0.001 |
WHtR | 49.20 (6.67) | 52.67 (6.41) | 54.24 (5.77) | 55.65 (5.43) | 56.56 5.37 () | < 0.001 |
TC (mmol.l-1) | 4.94 (0.98) | 5.36 (0.99) | 5.50 (1.01) | 5.63 (1.07) | 5.87 (1.15) | < 0.001 |
HDL-C (mmol.l-1) | 1.22 (0.26) | 1.04 (0.18) | 0.95 (0.17) | 0.87 (0.16) | 0.77 (0.15) | < 0.001 |
TGs (mmol.l-1) | 0.98 (0.26) | 1.51 (0.28) | 2.01 (0.39) | 2.62 (0.50) | 4.35 (1.63) | < 0.001 |
Ln-TGs | -0.06 (0.28) | 0.39 (0.19) | 0.68 (0.19) | 0.95 (0.19) | 1.41 (0.32) | < 0.001 |
FPG (mmol.l-1) | 5.26 (1.44) | 5.26 (1.17) | 5.47 (1.64) | 5.80 (1.98) | 6.07 (2.34) | < 0.001 |
PCPG (mmol.l-1) | 5.80 (2.79) | 6.08 (2.77) | 6.61 (3.18) | 7.09 (4.01) | 7.66 (4.01) | < 0.001 |
Incident CVD | 2.4 (1.4-4.1) | 3.9 (2.7-5.8) | 6.3 (4.5-8.7) | 10.7 (8.5-13.5) | 11.9 (9.5-14.8) | < 0.001 |